Skip to main content
. 2019 Jan 6;7(1):1–9. doi: 10.12998/wjcc.v7.i1.1

Table 2.

Commonly used guidelines for the screening of neoplasia in inflammatory bowel disease

Society Commencement Risk stratification Interval
ECCO, 2017 8 yr post symptom onset Stricture or dysplasia, PSC, extensive colitis, severe active inflammation Annual
Mild to moderate active inflammation, post inflammatory polyps, or first degree relative with CRC 2-3 yr
None of the above features 5 yr
AGA, 2010 8 yr post diagnosis Active inflammation, stricture, post inflammatory polyps, history of dysplasia, first degree relative with CRC, PSC Annual
After 2 negative colonoscopies 1-3 yr
ACG, 2010 8-10 yr post diagnosis No risk stratification 1-2 yr
BSG, 2010 10 yr post symptom onset Moderate/severe active inflammation on the prior colonoscopy, stricture, dysplasia, PSC, first degree relative with CRC aged < 50 yr Annual
Mild active inflammation on prior colonoscopy, post inflammatory polyps, first degree relative with CRC aged > 50 yr 3 yr
Nil prior inflammation, left sided colitis or CD colitis affecting > 50% surface area of the colon 5 yr

ECCO: European Crohn’s and Colitis Organisation; AGA: American Gastroenterological Association; ACG: American College of Gastroenterology; BSG: British Society of Gastroenterology.